pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
371
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
STP-145G
Autoimmune Disorders
Sirnaomics Ltd
0
catalysts
Preclinical
STP-146G
Autoimmune Disorders
Sirnaomics Ltd
0
catalysts
Preclinical
STP-247G
Unspecified Immunological Disorders
Sirnaomics Ltd
0
catalysts
Phase 1
SYNCAR-001 + STK-009
Lupus Nephritis
← prev
page 7 of 13
next →
131
Pain
89
Neurology
1
Synthekine Inc
0
catalysts
Phase 3
TAK-881
Primary Immune Deficiency (PID)
$TAK
TAKEDA PHARMACEUTICAL CO LTD
0
catalysts
Preclinical
TB-500
Inflammation
PharmaTher Holdings Ltd
0
catalysts
Phase 2
TLL-018
Plaque Psoriasis (Psoriasis Vulgaris)
Hangzhou Highlightll Pharmaceutical Co Ltd
0
catalysts
Phase 1
TLY-012
Chronic Pancreatitis
D&D Pharmatech Co Ltd
0
catalysts
Phase 1
TNX-1500
Heart Transplant Rejection
$TNXP
Tonix Pharmaceuticals Holding Corp.
0
catalysts
Phase 1
TRE-515
Ovarian Cancer
Trethera Corp
0
catalysts
pre_registration
TRGFT-201
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Orca Biosystems Inc
0
catalysts
Phase 2
TRX-103
Crohn's Disease (Regional Enteritis)
Tr1X Inc
0
catalysts
Phase 2
Tregcel
Kidney Transplant Rejection
Singulera Therapeutics Inc
0
catalysts
Phase 1
VIS-171
Autoimmune Disorders
Visterra Inc
0
catalysts
Phase 1
VIS-954
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis)
Visterra Inc
0
catalysts
Phase 2
VLP-001
Peanut Allergy
Allergy Therapeutics Plc
0
catalysts
Phase 1
VYN-202
Fibrosis
$VYNE
VYNE Therapeutics Inc.
0
catalysts
Phase 2
Wiskott-Aldrich Syndrome
Wiskott-Aldrich Syndrome
Thrombopoietin receptor
Genethon SA
0
catalysts
Marketed
Xembify
Xembify (immune globulin (human)-klhw)
Primary Immune Deficiency (PID)
Grifols Biologicals Inc (Inactive)
0
catalysts
Marketed
Zoryve
Zoryve (roflumilast)
Seborrhea
$ARQT
Arcutis Biotherapeutics, Inc.
0
catalysts
pre_registration
abatacept biosimilar
Rheumatoid Arthritis
Dr. Reddy's Laboratories Ltd
0
catalysts
Marketed
acitretin
Acitretin (acitretin)
Psoriasis
Sigmapharm Laboratories LLC
0
catalysts
Marketed
adalimumab biosimilar
Simlandi (adalimumab-ryvk)
Hidradenitis Suppurativa
$ALVO
Alvotech
0
catalysts
Phase 2
afimetoran
Systemic Lupus Erythematosus
Toll-like receptor 7
Toll-like receptor 8
Beeline Medicines Corp
0
catalysts
Marketed
alclometasone dipropionate
Alclometasone Dipropionate (alclometasone dipropionate)
Atopic Dermatitis (Atopic Eczema)
Fougera Pharmaceuticals Inc
0
catalysts
Preclinical
alidornase alfa
alidornase alfa [INN]
Pulmonary Sarcoidosis
Sarcomed AB
0
catalysts
Phase 2
alpha-1 proteinase inhibitor (human)
Prolastin (alpha-1 proteinase inhibitor (human))
Lung Transplant Rejection
Neutrophil elastase
$TAK
TAKEDA PHARMACEUTICAL CO LTD
0
catalysts
Marketed
amcinonide
Amcinonide (amcinonide)
Psoriasis
Solubiomix LLC
0
catalysts
Marketed
amifampridine
Amifampridine (amifampridine)
Lambert–Eaton Myasthenic Syndrome (LEMS)
Lupin Ltd
0
catalysts
Marketed
amifampridine phosphate
Firdapse (amifampridine phosphate)
Lambert–Eaton Myasthenic Syndrome (LEMS)
$CPRX
CATALYST PHARMACEUTICALS, INC.
0
catalysts
